• HumAIn Podcast - Artificial Intelligence, Data Science, Developer Tools, and Technical Education

  • By: David Yakobovitch
  • Podcast
HumAIn Podcast - Artificial Intelligence, Data Science, Developer Tools, and Technical Education  By  cover art

HumAIn Podcast - Artificial Intelligence, Data Science, Developer Tools, and Technical Education

By: David Yakobovitch
  • Summary

  • David Yakobovitch explores AI for consumers through fireside conversations with industry thought leaders on HumAIn. From Chief Data Scientists and AI Advisors, to Leaders who advance AI for All, the HumAIn Podcast is the channel to release new AI products, to learn about industry trends, and to bridge the gap between humans and machines in the Fourth Industrial Revolution.

    David Yakobovitch
    Show more Show less
Episodes
  • Max Galka: How AI Transforms Decision-making on the Blockchain
    Feb 23 2024

    Max Galka: How AI Transforms Decision-making on the Blockchain

    [Audio] 

    Max Galka is the CEO of Elementus, the first universal search engine for blockchain and institutional grade crypto forensics solution.

    In this episode, we talk about all things Blockchain, Bitcoin, Data, and AI.

    Episode Links:  

    Max Galka LinkedIn: https://www.linkedin.com/in/maxgalka/

    Elementus Website: https://www.elementus.io/

    Podcast Details: 

    Podcast website: https://www.humainpodcast.com 

    Apple Podcasts: https://podcasts.apple.com/us/podcast/humain-podcast-artificial-intelligence-data-science/id1452117009 

    Spotify: https://open.spotify.com/show/6tXysq5TzHXvttWtJhmRpS 

    RSS: https://feeds.redcircle.com/99113f24-2bd1-4332-8cd0-32e0556c8bc9 

    Support and Social Media:  

    – LinkedIn: https://www.linkedin.com/in/davidyakobovitch/ 



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    Show more Show less
    31 mins
  • Steven Banerjee: How Machine Intelligence, NLP and AI is changing Health Care
    Sep 21 2022
    Steven Banerjee: How Machine Intelligence, NLP and AI is changing Health Care  [Audio] Podcast: Play in new window | DownloadSubscribe: Google Podcasts | Spotify | Stitcher | TuneIn | RSSSteven Banerjee is the CEO of NExTNet Inc. NExTNet is a Silicon Valley based technology startup pioneering natural language based Explainable AI platform to accelerate drug discovery and development. Steven is also the founder of Mekonos, a Silicon Valley based biotechnology company backed by world-class Institutional investors (pre-Series B) — pioneering proprietary cell and gene-engineering platforms to advance personalized medicine. He also advises Lumen Energy, a company that uses a radically simplified approach to deploy commercial solar. Lumen Energy makes it easy for building owners to get clean energy.  Please support this podcast by checking out our sponsors:Episode Links:  Steven Banerjee LinkedIn: https://www.linkedin.com/in/steven-banerjee/ Steven Banerjee Website: https://www.nextnetinc.com/ Podcast Details: Podcast website: https://www.humainpodcast.com Apple Podcasts: https://podcasts.apple.com/us/podcast/humain-podcast-artificial-intelligence-data-science/id1452117009 Spotify: https://open.spotify.com/show/6tXysq5TzHXvttWtJhmRpS RSS: https://feeds.redcircle.com/99113f24-2bd1-4332-8cd0-32e0556c8bc9 YouTube Full Episodes: https://www.youtube.com/channel/UCxvclFvpPvFM9_RxcNg1rag YouTube Clips: https://www.youtube.com/channel/UCxvclFvpPvFM9_RxcNg1rag/videos Support and Social Media:  – Check out the sponsors above, it’s the best way to support this podcast– Support on Patreon: https://www.patreon.com/humain/creators – Twitter: https://twitter.com/dyakobovitch – Instagram: https://www.instagram.com/humainpodcast/ – LinkedIn: https://www.linkedin.com/in/davidyakobovitch/ – Facebook: https://www.facebook.com/HumainPodcast/ – HumAIn Website Articles: https://www.humainpodcast.com/blog/ Outline: Here’s the timestamps for the episode: (05:20)- So I am a mechanical engineer by training. And I started my graduate research in semiconductor technologies with applications in biotech almost more than a decade ago, in the early 2010s. I was a Doctoral Fellow at IBM labs here in San Jose, California. And then I also ended up writing some successful federal grants with a gene sequencing pioneer at Stanford, and Ron Davis, before I went, ended up going to UC Berkeley for grad school research, and then I became a visiting researcher.  (09:28)- An average cost of bringing a drug to market is around $2.6 billion. It takes around 10 to 15 years, like from the earliest days of discovery, to launching into the market. And unfortunately, more than 96% of all drug R&D actually fails . This is a really bad social model. This creates this enormous burden on our society and our healthcare spending as well. One of the reasons I started NextNet was when I was running Mekonos, I kept on seeing a lot of our customers had this tremendous pain point of, where you go, there's all this demand and subject matter experts, as scientists, they're actually working with very little of the available biomedical evidence out there. And a lot of the times that actually leads to false discoveries. (13:40)- And so there are tools, they're all this plethora of bioinformatics tools and software and databases out there that are plagued with program bugs. They mostly lack documentation or have very complicated documentation and best, very technical UI’s. And for an average scientist or an average person in this industry, you really need to have a fairly deep grasp or a sophisticated understanding of database schemas and SQL querying and statistical modeling and coding and data science.  (22:36)- So, a transformer is potentially one of the greatest breakthroughs that has happened in NLP recently. It's basically a neural net architecture that was incorporated into NLP models by Google Brain researchers that came along in 2017 and 2018. And before transformers, your state of the art models and NLP basically were like, LSTM, like long term memories are the widely used architecture. (27:24)- So Sapiens is, our goal here is to really make biomedical data accessible and useful for scientific inquiry, using this platform, so that, your average person and industry, let's say a wet lab or dry lab scientist, or a VP of R&D or CSO, or let's say a director of research can ask and answer complex biological questions. And a better frame hypothesis to understand is very complex, multifactorial diseases. And a lot of the insights that Sapiens is extracting from all this, with publicly available data sources are proprietary to the company. And then you can map and upload your own internal data, and begin to really contextualize all that information, by uploading onto the Sapiens.  (31:34)- We are definitely looking for early adopters. This includes biotech companies, pharma, academic research labs, that would like ...
    Show more Show less
    31 mins
  • Steven Shwartz: How AI Will Impact Society Over the Next Ten Years
    Jun 12 2022
    [Audio] Podcast: Play in new window | DownloadSubscribe: Google Podcasts | Spotify | Stitcher | TuneIn | RSSSteve received his PhD from Johns Hopkins University in Cognitive Science where he began his AI research and also taught Statistics at Towson State University. After receiving his PhD in 1979, AI pioneer Roger Schank invited Steve to join the Yale University faculty as a postdoctoral researcher in Computer Science. In 1981, Roger asked Steve to help him start one of the first AI companies, Cognitive Systems, which progressed to a public offering in 1986.  Steve then started Esperant, which produced one of the leading Business Intelligence products of the 1990s. During the 1980s, Steve published 35 articles and a book on AI, spoke at many AI conferences, and received two commercial patents on AI. As the AI Winter of the 1990s set in, Steve transitioned into a career as a successful serial software entrepreneur and investor and created several companies that were either acquired or had a public offering.  He tries to use his unique perspective as an early AI researcher and statistician to both explain how AI works in simple terms, to explain why people should not worry about intelligent robots taking over the world, and to explain the steps we need to take as a society to minimize the negative impacts of AI and maximize the positive impacts. Please support this podcast by checking out our sponsors:Episode Links:  Steven Shwartz LinkedIn: https://www.linkedin.com/in/steveshwartz/ Steven Shwartz Twitter: https://twitter.com/sshwartz Steven Shwartz Website: https://www.device42.com Podcast Details: Podcast website: https://www.humainpodcast.com Apple Podcasts: https://podcasts.apple.com/us/podcast/humain-podcast-artificial-intelligence-data-science/id1452117009 Spotify: https://open.spotify.com/show/6tXysq5TzHXvttWtJhmRpS RSS: https://feeds.redcircle.com/99113f24-2bd1-4332-8cd0-32e0556c8bc9 YouTube Full Episodes: https://www.youtube.com/channel/UCxvclFvpPvFM9_RxcNg1rag YouTube Clips: https://www.youtube.com/channel/UCxvclFvpPvFM9_RxcNg1rag/videos Support and Social Media:  – Check out the sponsors above, it’s the best way to support this podcast– Support on Patreon: https://www.patreon.com/humain/creators – Twitter: https://twitter.com/dyakobovitch – Instagram: https://www.instagram.com/humainpodcast/ – LinkedIn: https://www.linkedin.com/in/davidyakobovitch/ – Facebook: https://www.facebook.com/HumainPodcast/ – HumAIn Website Articles: https://www.humainpodcast.com/blog/ Outline: Here’s the timestamps for the episode: (00:00) – Introduction(09:42) – So most of the things that are taking jobs for example, is conventional software, not AI software.(10:57)- Exactly. And that's automated but it's conventional software. It's not AI. And most of the examples of where computers are replacing people, it's conventional software. It's not AI software.(14:49)- How you get data quality into your AI models and it's what they do that's really interesting. And I hadn't actually focused on it until I talked to this company. There's a big industry to clean data for tools like business intelligence that have been around for a long time. And there are, there are companies that are multi-billion dollar companies that provide data, cleaning tools, data extraction, and so forth.(17:13)- Everybody thought that with AI, you could diagnose illnesses from medical images better than the radiologists. And it's never actually worked out that way. I have friends who are radiologists, who use those AI tools and they say yes, sometimes they find things that I might've missed. But at the same time, they miss things that we would have found.(22:17)- I think we're seeing a lot of the rollout of a specific type of AI supervised learning, which is a type of machine learning. We're seeing it applied in many different areas. I actually have a database I keep before every time I see a new application of supervised learning and it's fascinating. It's being used in almost every area of business, of government, of the nonprofit world. It is fascinating how much application there is.  (27:06)- And they're not really going to make sense if you drill down into them. So what's going to be the implication of that. Is it only going to be useful if there's all kinds of search engine optimization where you don't really care If what you're right makes sense. We're going to generate a lot of crap using GPT three and put it out there for search engine optimization purposes.(31:19)- And I think there's a lot of opportunity for companies that are helping develop software and services to help companies build non-biased explainable systems. And then you have a whole issue around when you build a machine learning system, it deteriorates over time. So it might only work for a couple of days and then start to go downhill. It might work for weeks, but you have to monitor those systems and go back and ...
    Show more Show less
    34 mins

What listeners say about HumAIn Podcast - Artificial Intelligence, Data Science, Developer Tools, and Technical Education

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.